BIOSPECIFICS TECHNOLOGIES CORP Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 6 rows in 2018. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2018-08-29: Reporting owner Schamroth Michael; Form 4; Security Stock Option (Right to Buy); Transaction M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3.
- 2018-08-02: Reporting owner Wegman Thomas; Form 4; Security Stock Option (Right to Buy); Transaction C Conversion of derivative security.
- 2018-06-20: Reporting owner Wegman Mark N; Form 4; Security Stock Option (Right to Buy); Transaction C Conversion of derivative security.
- 2018-06-04: Reporting owner Schamroth Michael; Form 4; Security Stock Option (Right to Buy); Transaction C Conversion of derivative security.
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2018-08-29 | Schamroth Michael Director | 4 | Stock Option (Right to Buy) Derivative · Direct | M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | −15,000 0 owned after | $20.00 exercise price | 2018-08-30 | |
| 2018-08-02 | Wegman Thomas Director, Officer (President) | 4 | Stock Option (Right to Buy) Derivative · Direct | C Conversion of derivative security | −50,000 0 owned after | $21.00 exercise price | 2018-08-02 | |
| 2018-06-20 | Wegman Mark N Director | 4 | Stock Option (Right to Buy) Derivative · Direct | C Conversion of derivative security | −15,000 0 owned after | $17.00 exercise price | 2018-06-20 | |
| 2018-06-04 | Schamroth Michael Director | 4 | Stock Option (Right to Buy) Derivative · Direct | C Conversion of derivative security | −15,000 0 owned after | $13.60 exercise price | 2018-06-04 | |
| 2018-03-15 | Chao Jennifer M Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $41.82 exercise price | 2018-03-19 | |
| 2018-03-15 | Mattila Jyrki Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +15,000 15,000 owned after | $41.82 exercise price | 2018-03-19 |